Renaissance Technologies Portfolio holdings
Renaissance Technologies is a hedge fund firm that trades with computer models built on mathematics and statistics. It began in 1978 as Monemetrics, founded by Jim Simons, a mathematician and former Cold War codebreaker, and took its current name in 1982. The firm launched its Medallion Fund in 1988 and staffs its research with mathematicians, statisticians, physicists, astronomers and computer scientists. Medallion trades over short time spans across many asset types, and it has been closed to outside investors since 1993, open only to current and past employees and their families.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.07% |
| 2 | Technology | 14.35% |
| 3 | Financials | 11.23% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Real Estate | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
VeriSign
VRSN
$27.6B
| $1.61B | 1.42% |
7,688,276
+357,400
| +5% | +$70.2M |
2013 Q2
24 quarters
|
|
2
Chipotle Mexican Grill
CMG
$40.3B
| $1.31B | 1.16% |
89,574,950
+16,555,000
| +23% | +$233M |
2016 Q4
10 quarters
|
|
3
Novo Nordisk
NVO
$176B
| $1.15B | 1.01% |
45,043,832
+2,354,000
| +6% | +$58.2M |
2013 Q2
24 quarters
|
|
4
Palo Alto Networks
PANW
$299B
| $1.03B | 0.91% |
30,446,100
+3,541,200
| +13% | +$132M |
2015 Q2
16 quarters
|
|
5
Vertex Pharmaceuticals
VRTX
$142B
| $1.02B | 0.9% |
5,555,817
+477,100
| +9% | +$83.4M |
2017 Q1
9 quarters
|
|
|
6
Bristol-Myers Squibb
BMY
$128B
| $939M | 0.83% |
20,698,607
+8,347,432
| +68% | +$389M |
2016 Q2
12 quarters
|
|
7
Gilead Sciences
GILD
$212B
| $861M | 0.76% |
12,740,248
+4,620,000
| +57% | +$304M |
2014 Q4
18 quarters
|
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $826M | 0.73% |
8,935,785
+4,122,685
| +86% | +$391M |
2016 Q2
12 quarters
|
|
9
Starbucks
SBUX
$118B
| $788M | 0.69% |
9,403,002
-1,670,984
| -15% | -$131M |
2018 Q4
2 quarters
|
|
10
Humana
HUM
$49.8B
| $780M | 0.69% |
2,940,100
-170,900
| -5% | -$43.3M |
2015 Q2
16 quarters
|
|
11
PepsiCo
PEP
$187B
| $774M | 0.68% |
5,900,214
-1,288,300
| -18% | -$165M |
2013 Q2
24 quarters
|
|
12
Duke Energy
DUK
$99.3B
| $743M | 0.65% |
8,419,329
+263,100
| +3% | +$23.3M |
2014 Q1
21 quarters
|
|
13
Align Technology
ALGN
$10.6B
| $695M | 0.61% |
2,537,681
+277,681
| +12% | +$83.9M |
2013 Q2
24 quarters
|
|
14
Meta Platforms (Facebook)
META
$1.6T
| $661M | 0.58% |
3,423,861
-434,835
| -11% | -$79.4M |
2018 Q2
4 quarters
|
|
15
Domino's
DPZ
$10.3B
| $648M | 0.57% |
2,330,000
-443,500
| -16% | -$121M |
2013 Q2
24 quarters
|
|
|
VMW
16
DELISTED
VMware, Inc
VMW
| $644M | 0.57% |
3,850,311
-732,489
| -16% | -$137M |
2014 Q3
19 quarters
|
|
|
ABMD
17
DELISTED
Abiomed Inc
ABMD
| $633M | 0.56% |
2,431,723
+370,800
| +18% | +$98.4M |
2015 Q1
17 quarters
|
|
18
Petrobras
PBR
$142B
| $627M | 0.55% |
40,251,000
+5,532,200
| +16% | +$84.4M |
2016 Q2
12 quarters
|
|
19
GSK
GSK
$99.2B
| $611M | 0.54% |
12,209,425
+791,345
| +7% | +$39.7M |
2013 Q2
24 quarters
|
|
|
20
Johnson & Johnson
JNJ
$658B
| $605M | 0.53% |
4,341,162
+2,572,695
| +145% | +$356M |
2015 Q3
15 quarters
|
|
21
Atlassian
TEAM
$48.5B
| $603M | 0.53% |
4,607,600
+756,100
| +20% | +$91.1M |
2016 Q2
12 quarters
|
|
22
Biogen
BIIB
$37.5B
| $581M | 0.51% |
2,483,077
+851,263
| +52% | +$197M |
2018 Q1
5 quarters
|
|
23
Hershey
HSY
$33.3B
| $568M | 0.5% |
4,240,564
+1,589,800
| +60% | +$202M |
2013 Q2
24 quarters
|
|
24
TSMC
TSM
$2.11T
| $560M | 0.49% |
14,302,152
+5,643,870
| +65% | +$232M |
2018 Q1
5 quarters
|
|
|
25
GE Aerospace
GE
$313B
| $559M | 0.49% |
10,687,984
+7,676,498
| +255% | +$378M |
2019 Q1
1 quarter
|
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 494 new, 1,846 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 494 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.